Loading stock data…
DOCS
$24.98+0.54 (+2.21%)
Market ClosedLast close May 1
Doximity, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Doximity, Inc. in the Healthcare sector is trading at $24.98. The stock is currently near its 52-week low of $20.55, remaining 47.5% below its 200-day moving average. Technical signals show neutral RSI of 66 and bullish MACD crossover, explaining why DOCS maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 66) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$24.98
Potential Upside
11.7%
Whystock Fair Value$27.89
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus22 analysts
Buy
Mean target$37.77+51.2%
Range$25.00 – $55.00
Fundamentals
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the l...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.57B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
20.39
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.42
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
23.82%
Volume
Today's trading volume
2.66M
Recent News
Doximity (DOCS) Outperforms Broader Market: What You Need to Know
In the latest trading session, Doximity (DOCS) closed at $24.66, marking a +2.71% move from the previous day.
Wall Street Analysts Think Doximity (DOCS) Is a Good Investment: Is It?
The average brokerage recommendation (ABR) for Doximity (DOCS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine?
OptimizeRx rides AI-driven engagement gains, as oncology pilots scale to multi-brand deals and med tech traction fuels rising enterprise investment momentum.
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform
HIMS is building a data-driven care platform, adding Labs and multi-cancer testing to personalize treatment via continuous monitoring insights.
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know
Doximity (DOCS) reached $24.39 at the closing of the latest trading day, reflecting a -1.3% change compared to its last close.